ADAM19 was also reported as a miRNA target in the treatment of several cancers such as colorectal cancer, non-small cell lung cancer, and retinoblastoma, with the goal to inhibit proliferation, migration and invasion [67–69]. Here, ADAM19 is linked to colorectal cancer.